These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37807421)

  • 21. Transarterial administration of integrin inhibitor loaded nanoparticles combined with transarterial chemoembolization for treating hepatocellular carcinoma in a rat model.
    Qian J; Oppermann E; Tran A; Imlau U; Qian K; Vogl TJ
    World J Gastroenterol; 2016 Jun; 22(21):5042-9. PubMed ID: 27275096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transarterial chemoembolization and yittrium-90 for liver cancer and other lesions.
    Minocha J; Salem R; Lewandowski RJ
    Clin Liver Dis; 2014 Nov; 18(4):877-90. PubMed ID: 25438288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and Efficacy of Liver Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma After Segmental Transarterial Radioembolization.
    Hardy-Abeloos C; Lazarev S; Ru M; Kim E; Fischman A; Moshier E; Rosenzweig K; Buckstein M
    Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):968-976. PubMed ID: 31536781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Chemoembolization, Radioembolization, and Transarterial Ethanol Ablation for Huge Hepatocellular Carcinoma (≥ 10 cm) in Tumour Response and Long-Term Survival Outcome.
    Yu SCH; Hui JW; Li L; Cho CC; Hui EP; Chan SL; Yeo WM
    Cardiovasc Intervent Radiol; 2022 Feb; 45(2):172-181. PubMed ID: 34604920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pretransplant Intra-arterial Liver-Directed Therapy Does Not Increase the Risk of Hepatic Arterial Complications in Liver Transplantation: A Single-Center 10-Year Experience.
    Kallini JR; Gabr A; Ali R; Abouchaleh N; Riaz A; Baker T; Kulik L; Caicedo J; Salem R; Lewandowski RJ
    Cardiovasc Intervent Radiol; 2018 Feb; 41(2):231-238. PubMed ID: 28900709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ytrrium-90 transarterial radioembolization in patients with gastrointestinal malignancies.
    Viñal D; Minaya-Bravo A; Prieto I; Feliu J; Rodriguez-Salas N
    Clin Transl Oncol; 2022 May; 24(5):796-808. PubMed ID: 35013882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local application of doxorubicin- loaded Iron oxid nanoparticles and the vascular disrupting agent via the hepatic artery: chemoembolization-photothermal ablation treatment of hepatocellular carcinoma in rats.
    Yuan H; Li X; Tang J; Zhou M; Liu F
    Cancer Imaging; 2019 Nov; 19(1):71. PubMed ID: 31685015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radioembolization for the treatment of hepatocellular carcinoma.
    Kim HC
    Clin Mol Hepatol; 2017 Jun; 23(2):109-114. PubMed ID: 28494530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multifocal hepatocellular carcinoma: a narrative review assessing treatment options from the interventional radiologist's perspective.
    Narayanan A; Garza-Berlanga A; Lopera J
    Ann Palliat Med; 2023 Nov; 12(6):1244-1259. PubMed ID: 37574584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. French Interventional Radiology Centers' Uptake of Transradial Approach and Outpatient Hepatocellular Carcinoma Intra-Arterial Treatments.
    Grégory J; Ronot M; Laurent V; Chabrot P; de Baere T; Chevallier P; Vilgrain V; Aubé C;
    Cardiovasc Intervent Radiol; 2024 Apr; 47(4):432-440. PubMed ID: 37930400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained release hypoxia-activated prodrug-loaded BSA nanoparticles enhance transarterial chemoembolization against hepatocellular carcinoma.
    Hao Y; Zhu W; Li J; Lin R; Huang W; Ain QU; Liu K; Wei N; Cheng D; Wu Y; Lv W
    J Control Release; 2024 Aug; 372():155-167. PubMed ID: 38879131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiosomal radiopathologic analysis of transarterial radioembolization for the treatment of hepatocellular carcinoma.
    Ahmed AF; Samreen N; Grajo JR; Zendejas I; Sistrom CL; Collinsworth A; Esnakula A; Shah JL; Cabrera R; Geller BS; Toskich BB
    Abdom Radiol (NY); 2018 Jul; 43(7):1825-1836. PubMed ID: 29052747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transarterial Y90 radioembolization versus chemoembolization for patients with hepatocellular carcinoma: A meta-analysis.
    Zhang Y; Li Y; Ji H; Zhao X; Lu H
    Biosci Trends; 2015 Oct; 9(5):289-98. PubMed ID: 26559021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transarterial Chemoembolization vs Radioembolization for Neuroendocrine Liver Metastases: A Multi-Institutional Analysis.
    Egger ME; Armstrong E; Martin RC; Scoggins CR; Philips P; Shah M; Konda B; Dillhoff M; Pawlik TM; Cloyd JM
    J Am Coll Surg; 2020 Apr; 230(4):363-370. PubMed ID: 32032719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymer composite microspheres loading
    Xiao L; Li Y; Geng R; Chen L; Yang P; Li M; Luo X; Yang Y; Li L; Cai H
    Biomater Res; 2023 Nov; 27(1):110. PubMed ID: 37925456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transarterial Radioembolization Following Chemoembolization for Unresectable Hepatocellular Carcinoma: Response Based on Apparent Diffusion Coefficient Change is an Independent Predictor for Survival.
    Klompenhouwer EG; Dresen RC; Verslype C; Laenen A; Bonne L; Vandecaveye V; Maleux G
    Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1716-1726. PubMed ID: 29872894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion.
    de Baere T; Arai Y; Lencioni R; Geschwind JF; Rilling W; Salem R; Matsui O; Soulen MC
    Cardiovasc Intervent Radiol; 2016 Mar; 39(3):334-43. PubMed ID: 26390875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Idarubicin-loaded biodegradable microspheres enhance sensitivity to anti-PD1 immunotherapy in transcatheter arterial chemoembolization of hepatocellular carcinoma.
    Zheng Z; Ma M; Han X; Li X; Huang J; Zhao Y; Liu H; Kang J; Kong X; Sun G; Sun G; Kong J; Tang W; Shao G; Xiong F; Song J
    Acta Biomater; 2023 Feb; 157():337-351. PubMed ID: 36509402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transarterial Radioembolization versus Transarterial Chemoembolization Plus Percutaneous Ablation for Unresectable, Solitary Hepatocellular Carcinoma of ≥3 cm: A Propensity Score-Matched Study.
    Yu Q; Thapa N; Karani K; Navuluri R; Ahmed O; Van Ha T
    J Vasc Interv Radiol; 2022 Dec; 33(12):1570-1577.e1. PubMed ID: 36100064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autophagy-Targeted Calcium Phosphate Nanoparticles Enable Transarterial Chemoembolization for Enhanced Cancer Therapy.
    Yuan G; Xu Y; Bai X; Wang W; Wu X; Chen J; Li J; Jia X; Gu Z; Zhang X; Hu W; Wang J; Liu Y; Zhu XM
    ACS Appl Mater Interfaces; 2023 Mar; 15(9):11431-11443. PubMed ID: 36848495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.